Remote patient monitoring company Clear Arch Health on Thursday expanded its new connected health devices to ensure timely clinical touchpoints for Coronavirus Disease 2019 (COVID-19) and Chronic Obstructive Pulmonary Disease (COPD) management.
According to the company, the expanded product portfolio includes thermometer, peak flow meter, spirometer and pulse oximeter to support multiple conditions and provide clinical teams access to patient generated health data to manage high-risk patient populations.
In the wake of COVID-19, there is an increased need for telehealth services and access to remote health data as people have opted to avoid in-person care. Clinicians are concerned that delaying care, whether it is a routine visit or a necessary trip to the emergency room, could exacerbate symptoms or cause further health complications in patients with existing COPD, asthma and pneumonia, said the company.
The company's platform features offer multi-modal communications, including real time vitals monitoring, alert logic, compliance virtual reminders, enhanced audio, dedicated user interface with visual data, health-related surveys and questionnaires and patient education. All devices are wireless and automatically connect to a communications hub to notify clinical teams about a patient's health status.
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
Abbott's Navitor TAVI system granted CE Mark for expanded indication
PharmaResearch names VIVACY as European distribution partner for Rejuran
Airiver medical receives FDA approval for central airway stenosis trial